285 related articles for article (PubMed ID: 16301339)
1. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.
Sidney S; Petitti DB; Soff GA; Cundiff DL; Tolan KK; Quesenberry CP
Contraception; 2004 Jul; 70(1):3-10. PubMed ID: 15208046
[TBL] [Abstract][Full Text] [Related]
3. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
Duggan C; Marriott K; Edwards R; Cuzick J
J Clin Oncol; 2003 Oct; 21(19):3588-93. PubMed ID: 14512389
[TBL] [Abstract][Full Text] [Related]
4. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.
De Stefano V; Rossi E; Paciaroni K; D'Orazio A; Cina G; Marchitelli E; Pepe R; Leone G
Haematologica; 2003 Jan; 88(1):61-6. PubMed ID: 12551828
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
[TBL] [Abstract][Full Text] [Related]
7. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
Scarabin PY; Oger E; Plu-Bureau G;
Lancet; 2003 Aug; 362(9382):428-32. PubMed ID: 12927428
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of venous thromboembolism.
Kearon C
Semin Vasc Med; 2001; 1(1):7-26. PubMed ID: 15199510
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial.
Oger E; Alhenc-Gelas M; Lacut K; Blouch MT; Roudaut N; Kerlan V; Collet M; Abgrall JF; Aiach M; Scarabin PY; Mottier D;
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1671-6. PubMed ID: 12869355
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.
Martinelli I; Taioli E; Battaglioli T; Podda GM; Passamonti SM; Pedotti P; Mannucci PM
Arch Intern Med; 2003 Dec 8-22; 163(22):2771-4. PubMed ID: 14662632
[TBL] [Abstract][Full Text] [Related]
11. Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.
Legnani C; Cini M; Cosmi B; Poggi M; Boggian O; Palareti G
Haematologica; 2004 Nov; 89(11):1347-51. PubMed ID: 15531457
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for thrombophilia in extrahepatic portal vein obstruction.
Primignani M; Martinelli I; Bucciarelli P; Battaglioli T; Reati R; Fabris F; Dell'era A; Pappalardo E; Mannucci PM
Hepatology; 2005 Mar; 41(3):603-8. PubMed ID: 15726653
[TBL] [Abstract][Full Text] [Related]
13. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
Ogunyemi D; Cuellar F; Ku W; Arkel Y
Am J Perinatol; 2003 Jan; 20(1):17-24. PubMed ID: 12638077
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
[TBL] [Abstract][Full Text] [Related]
15. Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications.
De Stefano V; Rossi E; Leone G
Semin Vasc Med; 2003 Feb; 3(1):47-60. PubMed ID: 15199492
[TBL] [Abstract][Full Text] [Related]
16. Sex and gender issues and venous thromboembolism.
Moores L; Bilello KL; Murin S
Clin Chest Med; 2004 Jun; 25(2):281-97. PubMed ID: 15099889
[TBL] [Abstract][Full Text] [Related]
17. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
Gomes MP; Deitcher SR
Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism.
Bonduel M; Sciuccati G; Hepner M; Pieroni G; Torres AF; Mardaraz C; Frontroth JP
Am J Hematol; 2003 Jun; 73(2):81-6. PubMed ID: 12749008
[TBL] [Abstract][Full Text] [Related]
19. Association of factor V deficiency with factor V HR2.
Faioni EM; Castaman G; Asti D; Lussana F; Rodeghiero F
Haematologica; 2004 Feb; 89(2):195-200. PubMed ID: 15003895
[TBL] [Abstract][Full Text] [Related]
20. Estrogen plus progestin and risk of venous thrombosis.
Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
